Neovasc Inc. Receivables

Receivables of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Receivables growth rates and interactive chart. Accounts receivable (AR) is the balance of money due to a firm for goods or services delivered or used but not yet paid for by customers. Accounts receivables are listed on the balance sheet as a current asset. AR is any amount of money owed by customers for purchases made on credit. When a company makes a sale, it records revenues and a corresponding balance in accounts receivable. When an invoice is paid, the accounts payable account is reduced and cash is received. Receivables should grow in-line with revenue over time, if they are growing much faster, a company might be booking revenue too aggressively.


Highlights and Quick Summary

  • Receivables for the quarter ending March 31, 2022 was $1.41 Million (a 0.4% increase compared to previous quarter)
  • Year-over-year quarterly Receivables increased by 8.11%
  • Annual Receivables for 2021 was $1.41 Million (a 29.37% increase from previous year)
  • Annual Receivables for 2020 was $1.09 Million (a 35.71% increase from previous year)
  • Annual Receivables for 2019 was $800 Thousand (a 23.16% increase from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Receivables of Neovasc Inc.

Most recent Receivablesof NVCN including historical data for past 10 years.

Interactive Chart of Receivables of Neovasc Inc.

Neovasc Inc. Receivables for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $1.41
2021 $1.41 $1.85 $1.31 $1.17 $1.41
2020 $1.09 $0.96 $0.68 $0.83 $1.09
2019 $0.8 $0.54 $0.56 $0.72 $0.8
2018 $0.65 $0.8 $0.87 $0.75 $0.65
2017 $1.33 $1.39 $1.51 $2.15 $1.34
2016 $3.12 $2.02 $1.9 $3.12
2015 $1.74 $1.62 $1.39 $1.48 $1.74
2014 $1.54 $2.06 $1.22 $1.57 $1.54
2013 $1.25 $2.04 $1.66 $1.23 $1.25
2012 $1.24 $0.77 $0.53 $0.58 $1.24
2011 $0.73 $0.73

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.